133
Views
16
CrossRef citations to date
0
Altmetric
Original Article

Adherence and persistence in patients with postmenopausal osteoporosis treated with raloxifene

, , , &
Pages 228-235 | Received 13 Apr 2010, Accepted 03 Aug 2010, Published online: 21 Oct 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ellison D. Suthoff, Mac Bonafede, Brendan Limone, Lasair O’Callaghan, Gregory S. Sawicki & Jeffrey S. Wagener. (2016) Healthcare resource utilization associated with ivacaftor use in patients with cystic fibrosis. Journal of Medical Economics 19:9, pages 845-851.
Read now
Panagiotis Anagnostis & Spyridon N. Karras. (2015) Compliance with osteoporosis medications – an underestimated determinant of anti-fracture efficacy. Current Medical Research and Opinion 31:5, pages 1015-1016.
Read now
Jean-Yves Reginster, Serge Ferrari & Peyman Hadji. (2014) Current challenges in the treatment of osteoporosis: an opportunity for bazedoxifene. Current Medical Research and Opinion 30:6, pages 1165-1176.
Read now
Josep Darbà, Nuria Pérez-Álvarez, Lisette Kaskens, Susana Holgado-Pérez, Jill Racketa & Javier Rejas. (2013) Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain. ClinicoEconomics and Outcomes Research 5, pages 327-336.
Read now

Articles from other publishers (12)

Chong Li, Ke Lu, Qin Shi & Ya-qin Gong. (2022) Predicting the individualized risk of nonadherence to zoledronic acid among osteoporosis patients receiving the first infusion of zoledronic acid: development and validation of new predictive nomograms. Therapeutic Advances in Chronic Disease 13, pages 204062232211142.
Crossref
Deborah T. Gold. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis 1695 1707 .
C. T. Yeam, S. Chia, H. C. C. Tan, Y. H. Kwan, W. Fong & J. J. B. Seng. (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporosis International 29:12, pages 2623-2637.
Crossref
Jae-Hwi NhoYoung-Kyun LeeYong-Chan HaChung-Hyun KimYou-Sung SuhKyung-Hoi Koo. (2016) Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?. Journal of Bone Metabolism 23:2, pages 51.
Crossref
Lung-I Cheng, Emily Durden, Brendan Limone, Larry Radbill, Paul L. Juneau, Leslie Spangler, Faisal M. Mirza & Bradley S. Stolshek. (2015) Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States. Journal of Managed Care & Specialty Pharmacy 21:9, pages 824-833.
Crossref
S. W. Wade, S. Satram-Hoang & B. S. Stolshek. (2014) Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US™. Osteoporosis International 25:9, pages 2279-2290.
Crossref
Bing-Bing Qi & Barbara Resnick. (2014) Reliability and Validity of the Chinese Versions of Self-Efficacy and Outcome Expectations for Osteoporosis Medication Adherence Scales in Chinese Immigrants. Journal of Nursing Measurement 22:3, pages 472-488.
Crossref
Tien-Tsai Cheng, Shan-Fu Yu, Chung-Yuan Hsu, Sung-Hsiung Chen, Ben Yu-Jih Su & Tsong-Shing Yang. (2013) Differences in Adherence to Osteoporosis Regimens: A 2-Year Analysis of a Population Treated Under Specific Guidelines. Clinical Therapeutics 35:7, pages 1005-1015.
Crossref
Anne S Oberguggenberger, Monika Sztankay, Beate Beer, Birthe Schubert, Verena Meraner, Herbert Oberacher, Georg Kemmler, Johannes Giesinger, Eva Gamper, Barbara Sperner-Unterweger, Christian Marth, Bernhard Holzner & Michael Hubalek. (2012) Adherence evaluation of endocrine treatment in breast cancer: methodological aspects. BMC Cancer 12:1.
Crossref
P. Hadji, V. Ziller, D. Gamerdinger, W. Spieler, K. Articus, M. Baier, R. Moericke & P. H. Kann. (2011) Quality of life and health status with zoledronic acid and generic alendronate—a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass. Osteoporosis International 23:7, pages 2043-2051.
Crossref
Cristina Tamone, Gianfranco Fonte, Anna Panico, Pia Anna Molinatti, Patrizia D’Amelio & Giovanni Carlo Isaia. (2012) Impact of a Phone Follow-Up Program on Persistence with Teriparatide or PTH(1–84) Treatment. Calcified Tissue International 90:4, pages 272-278.
Crossref
J. A. Kanis, C. Cooper, M. Hiligsmann, V. Rabenda, J-Y. Reginster & R. Rizzoli. (2011) Partial adherence: a new perspective on health economic assessment in osteoporosis. Osteoporosis International 22:10, pages 2565-2573.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.